# PRECLINICAL MEDICATIONS SCREENING

> **NIH NIH N01** · TRUSTEES OF INDIANA UNIVERSITY · 2021 · $390,301

## Abstract

Developing medications for treatment of alcohol use disorder is a high priority for the National Institute on Alcohol Abuse and Alcoholism (NIAAA).  NIAAA has initiated a Preclinical Medication Efficacy Testing Program to foster discovery of medication targets and lead compounds to treat alcohol use disorder.  This program included the establishment of a coordinated infrastructure and network of preclinical laboratory models that can be employed to effectively screen potential therapeutics. A goal of this initiative was to facilitate the testing of clinically available pharmacotherapies as well as novel proprietary compounds in standardized preclinical models that capture key elements of alcohol use disorder.  Recognized as a critical step in the medications development process, information generated from this preclinical work is designed to both inform subsequent efforts to advance the evaluation of candidate compounds in human laboratory studies and controlled clinical trials.  This contract is for the blind efficacy testing of reference compounds and compounds of interest in preclinical models.

## Key facts

- **NIH application ID:** 10475556
- **Project number:** 75N94019C00009-P00003-9999-1
- **Recipient organization:** TRUSTEES OF INDIANA UNIVERSITY
- **Principal Investigator:** RICHARD L. BELL, PH.D.
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $390,301
- **Award type:** —
- **Project period:** 2019-09-29 → 2022-09-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10475556

## Citation

> US National Institutes of Health, RePORTER application 10475556, PRECLINICAL MEDICATIONS SCREENING (75N94019C00009-P00003-9999-1). Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/grant/nih/10475556. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*